menu

Schedule Call

Lymphoma Treatment Market - Global Outlook and Forecast 2022-2030

GR - 853383 Category: Pharmaceuticals

Number of pages:   |  Report Format: PDF  |  Published date: 01 November, 2022

Historical Years –   |  Base Year –   |  Forecasted Years –


Report Overview

Market Fundamentals

Lymphoma is a type of cancer which is found in lymph node and the cancer can spread throughout body. This type of cancer is curable if get discovered at an early stage. The 5 years all survival rate of Hodgkin lymphoma is 92% and Non-Hodgkin lymphoma is 62%. This is only if the disease is identified at a primary stage. The rising prevalence of lymphoma and growing awareness about the early diagnosis and treatment of the disease contributes to the growth of the lymphoma treatment market. Moreover, strong product pipeline, and continuous launch of advanced drugs further facilitates the market expansion. Additionally, the rapid adoption of innovative treatments such as immunotherapy or targeted therapy is also expected to fuel the market growth.

The global lymphoma treatment market report presents in-depth assessment of this industry with specific focus on global and regional trends and future outlook. This report aims at providing global and regional segment analysis based on categories such as types, therapy types, distribution channel and geography. The study also proposes to include study of the prevalent market drivers, restraints and future opportunities on the global landscape. 

Market Ecosystem

Global Lymphoma Treatment Market, by Type

  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma

Global Lymphoma Treatment Market, by Therapy Type 

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Others (Radiation Therapy, Biologic Therapy, etc.)

Global Lymphoma Treatment Market, by Distribution Channel

  • Online Pharmacies
  • Hospital Pharmacies
  • Drugs Store

Global Lymphoma Treatment Market, by Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Rest of the World
    • Latin America
    • Middle East & Africa

Key Market Trends

North America dominates the global lymphoma treatment market with the largest revenue share. This can be attributed to large patient base, rapid adoption of advanced treatments, continual launch of novel & effective therapies, and high awareness of the disease among the population. Furthermore, strong product pipeline, increased initiatives in R&D, and an enormous healthcare expenditure contributes to the market growth in this region. Whereas Europe holds the second largest revenue share in the market owing to the growing prevalence of lymphoma and increased technological advancement. Asia Pacific, on the other hand is an emerging region in this market due to its improving healthcare expenditure, growing awareness about this medical condition, and rising adoption of advanced treatments.   

Key Components of the Report 

  • In-depth review of the prevalent market trends
  • Annualized market size and forecast of every segment across 5 regions and 12 countries from 2020 to 2030
  • Market specific analysis of the segments on global level and further elaboration of trends in each region and country
  • Competitive landscape of the global market by key market players, based on market share or competitive positioning
  • Profiles of major market players based on business landscape, financial growth, and depth of product portfolio

Key Market Players 

Novartis AG, Bristol Myers Squibb Company, Genentech Inc. (F. Hoffmann-La Roche Ltd), Merck & Co. Inc., Spectrum Pharmaceuticals Inc., Bayer AG., AbbVie Inc., Janssen Pharmaceuticals Inc., Gilead Sciences Inc., Kyowa Kirin Co. Ltd., Takeda Pharmaceutical Company Limited, and others. 

Reasons to Buy this Report 

  • Detailed analysis of the impact of COVID-19 pandemic on the global Lymphoma Treatment Market
  • Develop your growth strategies through a review of the prevalent market trends, innovations, segment analysis, regional market landscape and future opportunities
  • Identify the competitive landscape of the global market and understand the intensity of competition 
  • Identify the emerging market players and develop effective competitive strategies to overcome the competition
  • Track the revenue growth of the global, region and country-level markets and make effective expansion decisions
  • Our robust sources and research methodologies deliver accurate market sizing and forecast, which are further validated by authentic primary sources including CMOs from major market players and key opinion leaders

Frequently Asked Questions About This Report

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  3. PREMIUM INSIGHTS
    1. Current Market Trend (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL LYMPHOMA TREATMENT MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Non-Hodgkin Lymphoma
    2. Hodgkin Lymphoma
  6. GLOBAL LYMPHOMA TREATMENT MARKET - ANALYSIS & FORECAST, BY THERAPY TYPE
    1. Chemotherapy
    2. Targeted Therapy
    3. Immunotherapy
    4. Others (Radiation Therapy, Biologic Therapy, etc.)
  7. GLOBAL LYMPHOMA TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Online Pharmacies
    2. Hospital Pharmacies
    3. Drugs Store
  8. GLOBAL LYMPHOMA TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Lymphoma Treatment Market
      1. North America Lymphoma Treatment Market, by Type
      2. North America Lymphoma Treatment Market, by Therapy Type
      3. North America Lymphoma Treatment Market, by Distribution Channel
      4. North America Lymphoma Treatment Market, by Country
        1. U.S.
          1. U.S. Lymphoma Treatment Market, by Type
          2. U.S. Lymphoma Treatment Market, by Therapy Type
          3. U.S. Lymphoma Treatment Market, by Distribution Channel
        2. Canada
          1. Canada Lymphoma Treatment Market, by Type
          2. Canada Lymphoma Treatment Market, by Therapy Type
          3. Canada Lymphoma Treatment Market, by Distribution Channel
    2. Europe Lymphoma Treatment Market
      1. Europe Lymphoma Treatment Market, by Type
      2. Europe Lymphoma Treatment Market, by Therapy Type
      3. Europe Lymphoma Treatment Market, by Distribution Channel
      4. Europe Lymphoma Treatment Market, by Country/Region
        1. Germany
          1. Germany Lymphoma Treatment Market, by Type
          2. Germany Lymphoma Treatment Market, by Therapy Type
          3. Germany Lymphoma Treatment Market, by Distribution Channel
        2. U.K.
          1. U.K. Lymphoma Treatment Market, by Test Type
          2. U.K. Lymphoma Treatment Market, by End User
        3. Spain
          1. Spain Lymphoma Treatment Market, by Type
          2. Spain Lymphoma Treatment Market, by Therapy Type
          3. Spain Lymphoma Treatment Market, by Distribution Channel
        4. Italy 
          1. Italy Lymphoma Treatment Market, by Type
          2. Italy Lymphoma Treatment Market, by Therapy Type
          3. Italy Lymphoma Treatment Market, by Distribution Channel
        5. France
          1. France Lymphoma Treatment Market, by Type
          2. France Lymphoma Treatment Market, by Therapy Type
          3. France Lymphoma Treatment Market, by Distribution Channel
        6. Rest of Europe 
          1. Rest of Europe Lymphoma Treatment Market, by Type
          2. Rest of Europe Lymphoma Treatment Market, by Therapy Type
          3. Rest of Europe Lymphoma Treatment Market, by Distribution Channel
    3. Asia Pacific Lymphoma Treatment Market
      1. Asia Pacific Lymphoma Treatment Market, by Type
      2. Asia Pacific Lymphoma Treatment Market, by Therapy Type
      3. Asia Pacific Lymphoma Treatment Market, by Distribution Channel
      4. Asia Pacific Lymphoma Treatment Market, by Country/Region
        1. China
          1. China Lymphoma Treatment Market, by Type
          2. China Lymphoma Treatment Market, by Therapy Type
          3. China Lymphoma Treatment Market, by Distribution Channel
        2. Japan
          1. Japan Lymphoma Treatment Market, by Type
          2. Japan Lymphoma Treatment Market, by Therapy Type
          3. Japan Lymphoma Treatment Market, by Distribution Channel
        3. India
          1. India Lymphoma Treatment Market, by Type
          2. India Lymphoma Treatment Market, by Therapy Type
          3. India Lymphoma Treatment Market, by Distribution Channel
        4. South Korea
          1. South Korea Lymphoma Treatment Market, by Type
          2. South Korea Lymphoma Treatment Market, by Therapy Type
          3. South Korea Lymphoma Treatment Market, by Distribution Channel
        5. Australia
          1. Australia Lymphoma Treatment Market, by Type
          2. Australia Lymphoma Treatment Market, by Therapy Type
          3. Australia Lymphoma Treatment Market, by Distribution Channel
        6. Rest of Asia Pacific 
          1. Rest of Asia Pacific Lymphoma Treatment Market, by Type
          2. Rest of Asia Pacific Lymphoma Treatment Market, by Therapy Type
          3. Rest of Asia Pacific Lymphoma Treatment Market, by Distribution Channel
    4. Rest of the World Lymphoma Treatment Market
      1. Rest of the World Lymphoma Treatment Market, By Region
        1. Rest of the World Lymphoma Treatment Market, by Type
        2. Rest of the World Lymphoma Treatment Market, by Therapy Type
        3. Rest of the World Lymphoma Treatment Market, by Distribution Channel
        4. Latin America
          1. Latin America Lymphoma Treatment Market, by Type
          2. Rest of the World Lymphoma Treatment Market, by Therapy Type
          3. Rest of the World Lymphoma Treatment Market, by Distribution Channel
        5. Middle East & Africa
          1. Middle East & Africa Lymphoma Treatment Market, by Type
          2. Middle East & Africa Lymphoma Treatment Market, by Therapy Type
          3. Middle East & Africa Lymphoma Treatment Market, by Distribution Channel
  9. COMPANY PROFILES        
    1. Novartis AG
      1. Business Snapshot 
      2. Products/Services Offered
      3. Financial Details*
      4. Strategic Developments
    2. Bristol Myers Squibb Company
    3. Genentech Inc. (F. Hoffmann-La Roche Ltd)
    4. Merck & Co. Inc.
    5. Spectrum Pharmaceuticals Inc.
    6. Bayer AG.
    7. AbbVie Inc.
    8. Janssen Pharmaceuticals Inc.
    9. Gilead Sciences Inc.
    10. Kyowa Kirin Co. Ltd.
    11. Takeda Pharmaceutical Company Limited 

*Insights on financial performance are subject to the availability of information in the public domain


Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.

Using the fundamental research and knowledge services capabilities of GRG Health, Growth Plus Reports may now be tailored based on client needs.

GRG Health's unique GrowthMIX strategy and comprehensive research methodology enable us to provide unique and valuable insights to our clients while uncovering trends that would not be discovered using traditional techniques.

sans

Snehal Deshmukh

Principle Consultant

Speak to analyst